Obexelimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Obexelimab, covering 2025-06-25 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease [Phase 3]